Developer docs
API playgroundTry for free, no card

Search company profiles

Prevent

Full company profile

uuid000eyfr

Namestring
Prevent
Legal namestring
株式会社PREVENT
Websiteurl
prevent.co.jp
Company typeenum
Private
Founded yearint
2016
Descriptiontext

PREVENT Co., Ltd. is a Nagoya, Japan-based healthcare technology company founded in July 2016 as a spin-off from the Nagoya University Medical Department. The company focuses on lifestyle disease escalation prevention (重症化予防) — intervening with patients already being treated for hypertension, diabetes, dyslipidemia, and related conditions, a population underserved by Japan's conventional specific health guidance (特定保健指導) framework. Its platform is built around two core products: Myscope, a medical data analytics service that ingests health checkup results, medical receipt (レセプト) data, and qualification records to predict lifestyle and vascular disease onset risk for health insurance unions and municipalities; and Mystar, a fully-online 6-month disease management program combining a dedicated mobile application, wearable monitoring devices (blood pressure, steps, sleep, salt intake via urinalysis), and biweekly one-on-one coaching by medical specialists. Output is delivered entirely online, enabling nationwide reach without in-person visits, and the program reports a 95%+ completion rate.

The business sells primarily on a B2B basis to enterprise health insurance unions (健保組合) and local government National Health Insurance programs, with per-participant fees for Mystar and project/subscription-based fees for Myscope analytics. Supplementing the core platform are online seminars (starting at ¥275,000 per session, ¥550,000/year for the on-demand channel), medical consultation recommendation services, and a newer SaniQara sub-brand launched in November 2025 for musculoskeletal wellness (back pain, shoulder stiffness) that adds AI posture analysis and physiotherapist-led counseling. Revenue also derives from collaborative research and RWD analytics engagements with pharmaceutical companies (AstraZeneca, DISCOVERY, Boehringer Ingelheim, Novartis, Novo Nordisk). Approximately 200 health insurance unions have introduced Mystar, more than 10,000 individuals have been served, and 300,000+ health records are reported in the analytics asset. PREVENT became a wholly-owned subsidiary of Sumitomo Life Insurance in December 2023, with a regional office in Hamamatsu in addition to the Nagoya headquarters, and an internal Insight Lab that publishes peer-reviewed research to underpin evidence-based product development.

Short descriptiontext

PREVENT is a Nagoya-based Japanese healthcare technology company that provides online lifestyle disease escalation prevention and medical data analytics to enterprise health insurance unions, municipal governments, and corporations, anchored by Myscope risk-prediction analytics and the Mystar mobile coaching program.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNagoya, Japan
HQ citystring
Nagoya
HQ countrystring
Japan
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical data analytics, lifestyle disease prevention, health insurance services, corporate wellness programs, preventive healthcare technology
Industry5 codes
PRIMARYHLALADAD
Chronic Condition Management & Remote Monitoring (e.g., diabetes, HTN)
Healthcare & Life Sciences/Telehealth Platforms/Employer-Sponsored Virtual Care Platforms
SECONDARYHLALACAE
Chronic Condition Virtual Care & Disease Management (Payer-Sponsored)
Healthcare & Life Sciences/Telehealth Platforms/Payer-Sponsored Virtual Care Platforms
SECONDARYHLALADAK
Virtual Preventive Care & Wellness Coaching (incl. lifestyle medicine)
Healthcare & Life Sciences/Telehealth Platforms/Employer-Sponsored Virtual Care Platforms
SECONDARYHLAHACAI
Chronic Disease Remote Monitoring (COPD/CHF/HTN, Weight & Symptom Tracking)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLAEAAAH
Employer Wellness & Population Health Programs
Healthcare & Life Sciences/Health Insurance & Managed Care/Commercial (Employer-Sponsored) Health Insurance
SIC code1 code
  • Services-Health Services8000
Product category
Preventive Healthcare Software
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model5 records
1Mystar Program Fees
TypeSubscription Recurring
Description

Health insurance unions and corporations pay per-participant program fees for the 6-month lifestyle improvement program. Billed based on the number of enrolled participants. This is the primary revenue stream.

prevent.co.jp:443
2Myscope Data Analytics Services
TypeProfessional Services
Description

Health insurance unions and municipalities pay for medical data analysis services, including risk stratification reports and target identification. Typically project or subscription-based.

prevent.co.jp:443
3Online Seminar / Training Programs
TypeProfessional Services
Description

Fees for wellness seminars, online training content, and educational materials for corporate health management (健康経営). Plans range from Light (¥275,000+) to Premium, plus speaker dispatch at ¥55,000 per session.

prevent.co.jp:443
4SaniQara Services
TypeSubscription Recurring
Description

New revenue stream from corporate wellness services targeting back pain and shoulder stiffness. Includes assessment reports, seminars, face-to-face advice sessions, SaniQara BOX subscription, and AI posture check events.

prevent.co.jp:443
5Collaborative Research & Consulting
TypeProfessional Services
Description

Fee-for-service research collaborations with pharmaceutical companies, local governments, and universities (e.g., CKD projects with AstraZeneca, HAE project with DISCOVERY, hypertension project in Nagano Prefecture).

prevent.co.jp:443
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
Pricing details4 tiers
1Light Plan for online seminars
ModelSubscriptionBilling cadenceOne-time / per event
Notes

Starting at ¥275,000 (tax-inclusive) per seminar session. Includes online seminar hosting, recruitment flyers, post-session surveys, and survey feedback.

prevent.co.jp
2Speaker dispatch for seminars
ModelUnit PricingBilling cadenceOne-time / per event
Notes

¥55,000 (tax-inclusive) per seminar session when sending instructor to client site.

prevent.co.jp
3On-demand video streaming (annual)
ModelSubscriptionBilling cadenceAnnual
Notes

¥550,000 (tax-inclusive) per year for the PREVENT CHANNEL on-demand video platform. Introductory campaign pricing available.

prevent.co.jp
4SaniQara customized plans
ModelHybridBilling cadenceQuote-based
Notes

Pricing is customized based on client company challenges, scale, number of employees, and chosen service modules (assessment reports, seminars, face-to-face advice sessions, SaniQara BOX, AI posture check). Contact for quote.

prevent.co.jp:443
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1SaniQara (サニカラ)
Description

A workplace health management sub-brand focused on preventing lower back pain and shoulder stiffness, offering services including assessment reports, online seminars, in-person consultation sessions, SaniQara BOX content delivery, and AI posture check events.

prevent.co.jp
Core offering1 text field

PREVENT sells a data-driven disease-prevention platform to Japanese health insurance unions, municipalities, and employers. Its core services are Myscope (medical data analytics that predict lifestyle and vascular disease risk) and Mystar (an online 6-month coaching program with a mobile app and monitoring devices for high-risk individuals already under treatment). The portfolio is rounded out by SaniQara (corporate musculoskeletal programs for low back pain and shoulder stiffness) and by online health-management seminars.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 84% of 56 high-risk participants showed lifestyle disease risk factor improvement in Hamamatsu PFS pilot program
+6 more records
Product overview1 text field

PREVENT operates a platform-plus-modules architecture centered on lifestyle disease escalation prevention. The core offerings are Myscope (medical data analytics for risk prediction) and Mystar (online disease management coaching with monitoring devices), supplemented by online seminars and medical consultation recommendation services. A newer sub-brand, SaniQara, launched in November 2025, extends the portfolio to musculoskeletal health (low back pain and shoulder stiffness prevention) for the working population. Research and evidence generation are handled by the PREVENT Insight Lab division.

Product and service5 records
1Myscope
CategoryHealthcare data analytics
Description

A medical data analysis service for Japanese health insurance unions (健康保険組合) and local governments that ingests health-checkup results, medical claims (レセプト) data, and other medical data to predict lifestyle-disease and vascular-disease onset risk, score and rank insured persons by future risk, and enable targeted extraction of high-risk individuals for intervention programs.

2Mystar
CategoryOnline disease management program
Description

An online, fully-remote 6-month lifestyle-disease escalation-prevention program for individuals already being treated for hypertension, diabetes, dyslipidemia, cerebrovascular disease, or ischemic heart disease. Delivered via a dedicated mobile app with paired monitoring devices (blood pressure monitor, salt-intake urinalysis, Fitbit for activity and sleep), with biweekly 1-on-1 coaching calls from medical specialists; reported 95%+ program completion rate.

3Online Seminar Service (オンラインセミナー)
CategoryWellness education / seminars
Description

Tiered health-management and collaboration-health seminar package offered in online, in-person, and on-demand video formats covering topics including vascular disease, exercise, diet, sleep, mental health, and women's health; priced from ¥275,000 (Light) per session and ¥55,000 per in-person speaker dispatch, with annual on-demand video subscription available at ¥550,000.

4Medical Consultation Recommendation Service (受診勧奨サービス)
CategoryCare-navigation service
Description

A service that promotes early medical consultations to prevent worsening of lifestyle diseases, targeting individuals identified as high-risk through Myscope data analysis and encouraging appropriate medical care-seeking behavior.

5SaniQara (サニカラ)
CategoryCorporate musculoskeletal wellness
Description

Corporate sub-brand for preventing lower back pain and shoulder stiffness in working populations. Services include assessment reports, physiotherapist-led face-to-face advisory sessions, online seminars, AI posture-check events, and a monthly SaniQara BOX content subscription that combine evidence-based medicine with behavioral-change expertise.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership19 partners
1Ichinomiya City and Nagoya University Hospital (一宮市・名古屋大学医学部附属病院)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-04-06
Description

Partnership agreement signed April 6, 2026 for joint research and regional health problem-solving. Aims to maximize healthy life expectancy, work-life expectancy, and quality of life through collective expertise, technology, and assets.

prevent.co.jp
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-03-30
Description

Partnered with Shizuoka Prefecture and Izu City to support liver disease severity prevention efforts. PREVENT conducted liver disease-related data analysis for the initiative addressing MASLD/MASH.

3Iwaki City Medical Association / Boehringer Ingelheim (いわき市医師会・ベーリンガーインゲルハイム)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-09-30
Description

Iwaki Heart Failure Discovery Project: PREVENT collaborated with the local medical association and pharmaceutical company to promote cardiac function testing for at-risk residents. Quantitative evaluation showed increased BNP and NT-proBNP testing rates during the 4-month evaluation period.

prevent.co.jp
4Kochi Prefecture / Kochi University / Novartis Pharma (高知県・高知大学・ノバルティスファーマ)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-07-25
Description

PREVENT supported an ischemic heart disease prevention initiative by conducting data analysis, providing medical consultation recommendations, and performing objective program evaluation for Nankoku City's program.

prevent.co.jp
5Nagano Prefecture (長野県)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2023-10-31
Description

PREVENT was commissioned by Nagano Prefecture to support a hypertension management improvement initiative targeting untreated and treatment-interrupted hypertensive patients across all 77 municipalities' National Health Insurance programs.

prevent.co.jp
Strategic tierFlagship / CoreTypeStrategic or Co-development PartnerAnnounced on2023-04-03
Description

Three-party comprehensive partnership agreement signed November 2021. Kashima City MVM Healthcare project provides lifestyle disease prevention services to municipal residents. First social implementation case under the tripartite agreement. Won Sports Agency award 2022 and Japan Open Innovation Award 2025.

7DISCOVERY (Hereditary Angioedema Diagnostic Consortium / 一般법인遺伝性血管性浮腫診断コンソーシアム)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2023-03-07
Description

Partnership for rare disease early detection. Using PREVENT's real-world data to validate and improve HAE (hereditary angioedema) diagnostic prediction model developed by DISCOVERY. Validated on Japanese claims data achieving high detection accuracy.

prevent.co.jp
8Kawanishi Town / Kawanishi Sports Club (奈良県川西町・川西スポーツクラブ)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-10-21
Description

E-sports for frailty prevention consortium. PREVENT conducted program evaluation for a 3-month e-sports program for active seniors in Kawanishi Town, demonstrating improvements in physical function (TUG, SPPB scores) and cognitive function (MoCA-J).

prevent.co.jp
9Seto City (愛知県瀬戸市)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-10-07
Description

Partnership agreement for health and welfare business support. Focus on promoting integrated elderly health services and disease prevention using data-driven approaches.

10Konan Women's University (甲南女子大学)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-07-08
Description

Academic collaboration resulting in peer-reviewed publication (Circulation Reports) on the effectiveness of PREVENT's mobile health program for vascular disease risk reduction. Led by Konan Women's University PT lecturer Masashi Kanai.

prevent.co.jp
11Sugi Holdings / Sugi Pharmacy (スギ薬局)
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2022-06-06
Description

Co-hosted wellness webinar with Sugi Pharmacy combining PREVENT's disease prevention expertise with Sugi's specific health guidance experience. Jointly promoted health management education.

prevent.co.jp
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

Collaborative CKD (chronic kidney disease) awareness project with three health insurance unions and PREVENT. Featured in AstraZeneca's i2.JP (Healthcare Open Innovation Network) case studies.

13KDDI Research (KDDI総合研究所)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-08-26
Description

KDDI Research collaborated with PREVENT and Hamamatsu City on a public-private Pay-for-Success pilot (August 2021-August 2022) for lifestyle disease prevention among National Health Insurance members. The project validated a new PFS results-based payment model for municipal healthcare cost optimization.

prevent.co.jp
14Hamamatsu City (浜松市)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-08-26
Description

Municipal partnership for National Health Insurance lifestyle disease prevention. Included Pay-for-Success model validation and the 'Hamamatsu Wellness Lab' initiative. PREVENT established a local office in Hamamatsu to support the partnership.

15Sakai City / Sumitomo Life Insurance (堺市・住友生命)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-08-26
Description

Joint initiative with Sakai City and Sumitomo Life to provide health promotion and lifestyle disease prevention programs to National Health Insurance members who have not received specific health examinations.

16Unnan City / Sumitomo Life Insurance (雲南市・住友生命)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-06-28
Description

Three-party partnership (PREVENT, Unnan City, Sumitomo Life) for regional lifestyle disease prevention and fiscal sustainability. Aims to address health challenges and medical cost increases in the municipality.

prevent.co.jp
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-09-23
Description

Nagoya University and PREVENT entered a joint research agreement focused on CKD (chronic kidney disease) prevention. The collaboration involves Nagoya University Graduate School of Medicine (Nephrology, Prof. Maruyama), the Preventive Early Medical Care Creation Center (Prof. Adachi), and the Hospital Medical Development Department Data Center. The goal is to build mechanisms for CKD progression prediction and prevention effectiveness measurement using PREVENT's claims and health checkup data.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2018-09-05
Description

Business partnership announced September 2018 for collaboration in the health insurance and medical domain.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2017-03-29
Description

Business partnership signed March 2017 for service collaboration in the health/wellness domain.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Prevent

Preventive Healthcare Softwareprevent.co.jp

PREVENT is a Nagoya-based Japanese healthcare technology company that provides online lifestyle disease escalation prevention and medical data analytics to enterprise health insurance unions, municipal governments, and corporations, anchored by Myscope risk-prediction analytics and the Mystar mobile coaching program.

What Prevent does

PREVENT Co., Ltd. is a Nagoya, Japan-based healthcare technology company founded in July 2016 as a spin-off from the Nagoya University Medical Department. The company focuses on lifestyle disease escalation prevention (重症化予防) — intervening with patients already being treated for hypertension, diabetes, dyslipidemia, and related conditions, a population underserved by Japan's conventional specific health guidance (特定保健指導) framework. Its platform is built around two core products: Myscope, a medical data analytics service that ingests health checkup results, medical receipt (レセプト) data, and qualification records to predict lifestyle and vascular disease onset risk for health insurance unions and municipalities; and Mystar, a fully-online 6-month disease management program combining a dedicated mobile application, wearable monitoring devices (blood pressure, steps, sleep, salt intake via urinalysis), and biweekly one-on-one coaching by medical specialists. Output is delivered entirely online, enabling nationwide reach without in-person visits, and the program reports a 95%+ completion rate.

The business sells primarily on a B2B basis to enterprise health insurance unions (健保組合) and local government National Health Insurance programs, with per-participant fees for Mystar and project/subscription-based fees for Myscope analytics. Supplementing the core platform are online seminars (starting at ¥275,000 per session, ¥550,000/year for the on-demand channel), medical consultation recommendation services, and a newer SaniQara sub-brand launched in November 2025 for musculoskeletal wellness (back pain, shoulder stiffness) that adds AI posture analysis and physiotherapist-led counseling. Revenue also derives from collaborative research and RWD analytics engagements with pharmaceutical companies (AstraZeneca, DISCOVERY, Boehringer Ingelheim, Novartis, Novo Nordisk). Approximately 200 health insurance unions have introduced Mystar, more than 10,000 individuals have been served, and 300,000+ health records are reported in the analytics asset. PREVENT became a wholly-owned subsidiary of Sumitomo Life Insurance in December 2023, with a regional office in Hamamatsu in addition to the Nagoya headquarters, and an internal Insight Lab that publishes peer-reviewed research to underpin evidence-based product development.

Prevent firmographics

Firmographics
Name
Prevent
Legal name
株式会社PREVENT
Website
https://prevent.co.jp
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
PREVENT is a Nagoya-based Japanese healthcare technology company that provides online lifestyle disease escalation prevention and medical data analytics to enterprise health insurance unions, municipal governments, and corporations, anchored by Myscope risk-prediction analytics and the Mystar mobile coaching program.
Ownership category
akta.pro rank

Prevent industry classification

Industry
Product category
Preventive Healthcare Software
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLALADAD
Chronic Condition Management & Remote Monitoring (e.g., diabetes, HTN)
Healthcare & Life Sciences/Telehealth Platforms/Employer-Sponsored Virtual Care Platforms
SECONDARYHLALACAE
Chronic Condition Virtual Care & Disease Management (Payer-Sponsored)
Healthcare & Life Sciences/Telehealth Platforms/Payer-Sponsored Virtual Care Platforms
SECONDARYHLALADAK
Virtual Preventive Care & Wellness Coaching (incl. lifestyle medicine)
Healthcare & Life Sciences/Telehealth Platforms/Employer-Sponsored Virtual Care Platforms
SECONDARYHLAHACAI
Chronic Disease Remote Monitoring (COPD/CHF/HTN, Weight & Symptom Tracking)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLAEAAAH
Employer Wellness & Population Health Programs
Healthcare & Life Sciences/Health Insurance & Managed Care/Commercial (Employer-Sponsored) Health Insurance

Keywords

  • Medical data analytics
  • Lifestyle disease prevention
  • Health insurance services
  • Corporate wellness programs
  • Preventive healthcare technology

Where Prevent is headquartered

Location

Headquarters

HQ city
Nagoya
HQ country
Japan
HQ region
Asia

Offices2 records

Markets served

Prevent business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Mystar Program Fees: Health insurance unions and corporations pay per-participant program fees for the 6-month lifestyle improvement program. Billed based on the number of enrolled participants. This is the primary revenue stream.
  2. Myscope Data Analytics Services: Health insurance unions and municipalities pay for medical data analysis services, including risk stratification reports and target identification. Typically project or subscription-based.
  3. Online Seminar / Training Programs: Fees for wellness seminars, online training content, and educational materials for corporate health management (健康経営). Plans range from Light (¥275,000+) to Premium, plus speaker dispatch at ¥55,000 per session.
  4. SaniQara Services: New revenue stream from corporate wellness services targeting back pain and shoulder stiffness. Includes assessment reports, seminars, face-to-face advice sessions, SaniQara BOX subscription, and AI posture check events.
  5. Collaborative Research & Consulting: Fee-for-service research collaborations with pharmaceutical companies, local governments, and universities (e.g., CKD projects with AstraZeneca, HAE project with DISCOVERY, hypertension project in Nagano Prefecture).

Pricing tiers

ModelBillingPrice
SubscriptionOne-time / per eventLight Plan for online seminars
Unit PricingOne-time / per eventSpeaker dispatch for seminars
SubscriptionAnnualOn-demand video streaming (annual)
HybridQuote-basedSaniQara customized plans

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

Prevent product offering

Product offering

Core offering

PREVENT sells a data-driven disease-prevention platform to Japanese health insurance unions, municipalities, and employers. Its core services are Myscope (medical data analytics that predict lifestyle and vascular disease risk) and Mystar (an online 6-month coaching program with a mobile app and monitoring devices for high-risk individuals already under treatment). The portfolio is rounded out by SaniQara (corporate musculoskeletal programs for low back pain and shoulder stiffness) and by online health-management seminars.

Product overview

PREVENT operates a platform-plus-modules architecture centered on lifestyle disease escalation prevention. The core offerings are Myscope (medical data analytics for risk prediction) and Mystar (online disease management coaching with monitoring devices), supplemented by online seminars and medical consultation recommendation services. A newer sub-brand, SaniQara, launched in November 2025, extends the portfolio to musculoskeletal health (low back pain and shoulder stiffness prevention) for the working population. Research and evidence generation are handled by the PREVENT Insight Lab division.

Differentiator

Problem solved

Functional benefit

Brands

  • SaniQara (サニカラ): A workplace health management sub-brand focused on preventing lower back pain and shoulder stiffness, offering services including assessment reports, online seminars, in-person consultation sessions, SaniQara BOX content delivery, and AI posture check events.

Products and services

  • Myscope A medical data analysis service for Japanese health insurance unions (健康保険組合) and local governments that ingests health-checkup results, medical claims (レセプト) data, and other medical data to predict lifestyle-disease and vascular-disease onset risk, score and rank insured persons by future risk, and enable targeted extraction of high-risk individuals for intervention programs.
  • Mystar An online, fully-remote 6-month lifestyle-disease escalation-prevention program for individuals already being treated for hypertension, diabetes, dyslipidemia, cerebrovascular disease, or ischemic heart disease. Delivered via a dedicated mobile app with paired monitoring devices (blood pressure monitor, salt-intake urinalysis, Fitbit for activity and sleep), with biweekly 1-on-1 coaching calls from medical specialists; reported 95%+ program completion rate.
  • Online Seminar Service (オンラインセミナー) Tiered health-management and collaboration-health seminar package offered in online, in-person, and on-demand video formats covering topics including vascular disease, exercise, diet, sleep, mental health, and women's health; priced from ¥275,000 (Light) per session and ¥55,000 per in-person speaker dispatch, with annual on-demand video subscription available at ¥550,000.
  • Medical Consultation Recommendation Service (受診勧奨サービス) A service that promotes early medical consultations to prevent worsening of lifestyle diseases, targeting individuals identified as high-risk through Myscope data analysis and encouraging appropriate medical care-seeking behavior.
  • SaniQara (サニカラ) Corporate sub-brand for preventing lower back pain and shoulder stiffness in working populations. Services include assessment reports, physiotherapist-led face-to-face advisory sessions, online seminars, AI posture-check events, and a monthly SaniQara BOX content subscription that combine evidence-based medicine with behavioral-change expertise.

Quantifiable outcome

  • 84% of 56 high-risk participants showed lifestyle disease risk factor improvement in Hamamatsu PFS pilot program
  • +6 more outcomes

Companies that use Prevent

Customer profile

Named customers10 records

Segments4 records

Ideal customer profiles4 records

Prevent technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

Prevent partnerships and signals

Strategic signal

Partnerships

19 partnerships are on record, tiered minor, flagship / core and core.

  • Ichinomiya City and Nagoya University Hospital (一宮市・名古屋大学医学部附属病院)minorStrategic or Co-development Partner · 6 April 2026Partnership agreement signed April 6, 2026 for joint research and regional health problem-solving. Aims to maximize healthy life expectancy, work-life expectancy, and quality of life through collective expertise, technology, and assets.
  • Novo Nordisk Pharma (ノボ ノルディスク ファーマ)minorStrategic or Co-development Partner · 30 March 2026Partnered with Shizuoka Prefecture and Izu City to support liver disease severity prevention efforts. PREVENT conducted liver disease-related data analysis for the initiative addressing MASLD/MASH.
  • Iwaki City Medical Association / Boehringer Ingelheim (いわき市医師会・ベーリンガーインゲルハイム)minorStrategic or Co-development Partner · 30 September 2024Iwaki Heart Failure Discovery Project: PREVENT collaborated with the local medical association and pharmaceutical company to promote cardiac function testing for at-risk residents. Quantitative evaluation showed increased BNP and NT-proBNP testing rates during the 4-month evaluation period.
  • Kochi Prefecture / Kochi University / Novartis Pharma (高知県・高知大学・ノバルティスファーマ)minorStrategic or Co-development Partner · 25 July 2024PREVENT supported an ischemic heart disease prevention initiative by conducting data analysis, providing medical consultation recommendations, and performing objective program evaluation for Nankoku City's program.
  • Nagano Prefecture (長野県)minorStrategic or Co-development Partner · 31 October 2023PREVENT was commissioned by Nagano Prefecture to support a hypertension management improvement initiative targeting untreated and treatment-interrupted hypertensive patients across all 77 municipalities' National Health Insurance programs.
  • Kashima City / Sumitomo Life Insurance (鹿嶋市・住友生命)flagship / coreStrategic or Co-development Partner · 3 April 2023Three-party comprehensive partnership agreement signed November 2021. Kashima City MVM Healthcare project provides lifestyle disease prevention services to municipal residents. First social implementation case under the tripartite agreement. Won Sports Agency award 2022 and Japan Open Innovation Award 2025.
  • DISCOVERY (Hereditary Angioedema Diagnostic Consortium / 一般법인遺伝性血管性浮腫診断コンソーシアム)minorStrategic or Co-development Partner · 7 March 2023Partnership for rare disease early detection. Using PREVENT's real-world data to validate and improve HAE (hereditary angioedema) diagnostic prediction model developed by DISCOVERY. Validated on Japanese claims data achieving high detection accuracy.
  • Kawanishi Town / Kawanishi Sports Club (奈良県川西町・川西スポーツクラブ)minorStrategic or Co-development Partner · 21 October 2022E-sports for frailty prevention consortium. PREVENT conducted program evaluation for a 3-month e-sports program for active seniors in Kawanishi Town, demonstrating improvements in physical function (TUG, SPPB scores) and cognitive function (MoCA-J).
  • Seto City (愛知県瀬戸市)minorStrategic or Co-development Partner · 7 October 2022Partnership agreement for health and welfare business support. Focus on promoting integrated elderly health services and disease prevention using data-driven approaches.
  • Konan Women's University (甲南女子大学)minorStrategic or Co-development Partner · 8 July 2022Academic collaboration resulting in peer-reviewed publication (Circulation Reports) on the effectiveness of PREVENT's mobile health program for vascular disease risk reduction. Led by Konan Women's University PT lecturer Masashi Kanai.
  • Sugi Holdings / Sugi Pharmacy (スギ薬局)minorGTM or Marketing Partner · 6 June 2022Co-hosted wellness webinar with Sugi Pharmacy combining PREVENT's disease prevention expertise with Sugi's specific health guidance experience. Jointly promoted health management education.
  • AstraZeneca (アストラゼネカ)minorStrategic or Co-development Partner · 1 January 2022Collaborative CKD (chronic kidney disease) awareness project with three health insurance unions and PREVENT. Featured in AstraZeneca's i2.JP (Healthcare Open Innovation Network) case studies.
  • KDDI Research (KDDI総合研究所)coreStrategic or Co-development Partner · 26 August 2021KDDI Research collaborated with PREVENT and Hamamatsu City on a public-private Pay-for-Success pilot (August 2021-August 2022) for lifestyle disease prevention among National Health Insurance members. The project validated a new PFS results-based payment model for municipal healthcare cost optimization.
  • Hamamatsu City (浜松市)coreStrategic or Co-development Partner · 26 August 2021Municipal partnership for National Health Insurance lifestyle disease prevention. Included Pay-for-Success model validation and the 'Hamamatsu Wellness Lab' initiative. PREVENT established a local office in Hamamatsu to support the partnership.
  • Sakai City / Sumitomo Life Insurance (堺市・住友生命)minorStrategic or Co-development Partner · 26 August 2021Joint initiative with Sakai City and Sumitomo Life to provide health promotion and lifestyle disease prevention programs to National Health Insurance members who have not received specific health examinations.
  • Unnan City / Sumitomo Life Insurance (雲南市・住友生命)minorStrategic or Co-development Partner · 28 June 2021Three-party partnership (PREVENT, Unnan City, Sumitomo Life) for regional lifestyle disease prevention and fiscal sustainability. Aims to address health challenges and medical cost increases in the municipality.
  • Nagoya University (名古屋大学)coreStrategic or Co-development Partner · 23 September 2020Nagoya University and PREVENT entered a joint research agreement focused on CKD (chronic kidney disease) prevention. The collaboration involves Nagoya University Graduate School of Medicine (Nephrology, Prof. Maruyama), the Preventive Early Medical Care Creation Center (Prof. Adachi), and the Hospital Medical Development Department Data Center. The goal is to build mechanisms for CKD progression prediction and prevention effectiveness measurement using PREVENT's claims and health checkup data.
  • MedPeer Group (メドピアグループ)minorStrategic or Co-development Partner · 5 September 2018Business partnership announced September 2018 for collaboration in the health insurance and medical domain.
  • FiNCminorStrategic or Co-development Partner · 29 March 2017Business partnership signed March 2017 for service collaboration in the health/wellness domain.

Scale indicators7 records

Recent moves10 records

Expansion highlights6 records

Prevent competitors and assessment

Company assessment

Market position

Strengths5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Prevent social profiles

Digital presence

Prevent compliance and trust

Trust signal

Compliance2 records

Prevent financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Prevent leadership team

Management profile

Number of profiles

Profiles5 records

Prevent funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Prevent M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Prevent

What does Prevent do?

PREVENT sells a data-driven disease-prevention platform to Japanese health insurance unions, municipalities, and employers. Its core services are Myscope (medical data analytics that predict lifestyle and vascular disease risk) and Mystar (an online 6-month coaching program with a mobile app and monitoring devices for high-risk individuals already under treatment). The portfolio is rounded out by SaniQara (corporate musculoskeletal programs for low back pain and shoulder stiffness) and by online health-management seminars.

Is Prevent a public or private company?

Prevent is a private company. It is classified as corporate owned and is currently operating.

When was Prevent founded?

Prevent was founded in 2016. It employs 11 to 50 people.

Where is Prevent based?

Prevent is headquartered in Nagoya, Japan, in the Asia region.

How does Prevent make money?

Five revenue lines are on record. Mystar Program Fees are the primary driver. The others are myscope Data Analytics Services, online Seminar / Training Programs, saniQara Services and collaborative Research & Consulting.

Does Prevent have an API?

No public API is recorded for Prevent.

What industry is Prevent in?

Prevent's product category is Preventive Healthcare Software. Its primary akta.pro industry code is HLALADAD, Chronic Condition Management & Remote Monitoring (e.g., diabetes, HTN), with a secondary code of HLALACAE, Chronic Condition Virtual Care & Disease Management (Payer-Sponsored). Its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The SunMy girl, 14, was UK’s youngest terror suspect…she carved swastika on her head after being groomed online by neo-NazisRhianan Rudd, a UK teenager who was charged with terrorism offences after being groomed online by an American neo-Nazi, died by suicide at age 16 despite the charges against her having been dropped. An inquest into her death criticized the delayed recognition of her exploitation and the inappropriate timing of deradicalization sessions conducted by the Prevent programme immediately prior to her death.PrtimesPREVENT, which works on the prevention of the exacerbation of lifestyle-related diseases, has conducted fundraising through third-party allotment of shares from Sumitomo Life and Teijin.PREVENT Co., Ltd. has secured fundraising through a third-party allotment of shares from Sumitomo Life Insurance Company and Teijin Limited to expand its healthcare services for lifestyle-related diseases. The investment will facilitate business collaborations in InsurTech and regional healthcare, integrating PREVENT's high-risk approach with Sumitomo Life's population-based 'Vitality' program. This funding aims to accelerate the social implementation of living well with chronic conditions by enhancing existing services and product development.PreventBy conducting a third-party allocation of shares for fundraising from Sumitomo Life and Teijin, we will further strengthen the implementation of a society where one can live with illness through the expansion into surrounding areas including InsurTech.PREVENT Co., Ltd. conducted fundraising through a third-party share allocation involving Sumitomo Life Insurance Mutual Company and Teijin Limited. The company aims to strengthen the social implementation of 'one illness, one health' by enhancing existing services and expanding into peripheral areas such as InsurTech.